Your browser doesn't support javascript.
loading
Prevalence of Brucella melitensis and Brucella abortus aminoglycoside-resistant isolates: a systematic review and meta-analysis.
Moradkasani, Safoura; Goodarzi, Forough; Beig, Masoumeh; Tadi, Danyal Abbasi; Sholeh, Mohammad.
Afiliación
  • Moradkasani S; Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
  • Goodarzi F; Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Beig M; Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
  • Tadi DA; Student Research Committee, Pasteur Institute of Iran, Tehran, Iran.
  • Sholeh M; Department of Veterinary, Azad University of Shahr-E Kord, Shahrekord, Iran. danyalabbasitadi@gmail.com.
Braz J Microbiol ; 55(1): 429-439, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38228936
ABSTRACT

INTRODUCTION:

Aminoglycosides are vital antibiotics for treating Brucella infections, because they interfere with bacterial protein production and are often combined with other antibiotics. They are cost-effective, have fewer side effects, and can penetrate biofilms. The prevalence of brucellosis has increased in recent years, increasing the need for effective treatments. In addition, the emergence of multidrug-resistant Brucella strains has highlighted the need for an updated and comprehensive understanding of aminoglycoside resistance. This systematic review aimed to provide a comprehensive overview of the global prevalence of aminoglycoside resistance in B. melitensis and B. abortus.

METHODS:

A systematic search of online databases was conducted and eligible studies met certain criteria and were published in English. Quality assessment was performed using the JBI Checklist. A random-effects model was fitted to the data, and meta-regression, subgroup, and outlier/influential analyses were performed. The analysis was performed using R and the metafor package.

RESULTS:

The results of this systematic review and meta-analysis suggested that the average prevalence rates of streptomycin, gentamicin, and amikacin resistance were 0.027 (95% confidence interval [CI], 0.015-0.049), 0.023 (95% CI, 0.017-0.032), and 0.008 (95% CI, 0.002-0.039), respectively. The prevalence of streptomycin resistance was higher in the unidentified Brucella group than in the B. abortus and B. melitensis groups (0.234, 0.046, and 0.017, respectively; p < 0.02). The prevalence of gentamicin resistance increased over time (r = 0.064; 95% CI, 0.018 to 0.111; p = 0.007). The prevalence of resistance did not correlate with the quality score for any antibiotic. Funnel plots showed a potential asymmetry for streptomycin and gentamicin. These results suggest a low prevalence of antibiotic resistance in the studied populations.

CONCLUSION:

The prevalence of aminoglycoside resistance in B. melitensis and B. abortus was low. However, gentamicin resistance has increased in recent years. This review provides a comprehensive and updated understanding of aminoglycoside resistance in B. melitensis and B. abortus.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Brucella abortus / Brucelosis / Brucella melitensis / Aminoglicósidos / Antibacterianos Tipo de estudio: Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Braz J Microbiol Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Brucella abortus / Brucelosis / Brucella melitensis / Aminoglicósidos / Antibacterianos Tipo de estudio: Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Braz J Microbiol Año: 2024 Tipo del documento: Article